Hillen H, Wessels J, Haanen C
Lancet. 1975 Mar 15;1(7907):609-11. doi: 10.1016/s0140-6736(75)91887-5.
The proliferation patterns of normal and leukaemic bone-marrow were studied by measuring the D.N.A. content of large numbers of cells by pulse cytophotometry (P.C.P.). In nineteen normal bone-marrow samples an average of 66-3% of the bone-marrow cells were in the G1 phase (2n D.N.A.), 26-1% in the S phase (2n smaller than D.N.A. smaller than 4n), and 7-5% in G2+M phase (4n D.N.A.). The percentages of S-phase cells determined by autoradiography and P.C.P. correlated well, both in normal and in leukaemic bone-marrow. In 25 patients with untreated acute myeloblastic leukaemia (A.M.L.) lower percentages of cells were found in S and G2+M phases, indicating a smaller proliferating pool compared with normal bone-marrow. The likelihood of a complete remission being attained in A.M.L. with the first treatment course was correlated with the percentage of S-phase cells present before treatment. At remission in A.M.L. the proliferation pattern was restored to normal.
通过脉冲细胞光度法(P.C.P.)测量大量细胞的DNA含量,研究了正常和白血病骨髓的增殖模式。在19份正常骨髓样本中,平均66.3%的骨髓细胞处于G1期(2n DNA),26.1%处于S期(2n小于DNA小于4n),7.5%处于G2+M期(4n DNA)。通过放射自显影和P.C.P.测定的S期细胞百分比,在正常和白血病骨髓中都具有良好的相关性。在25例未经治疗的急性髓细胞白血病(A.M.L.)患者中,S期和G2+M期的细胞百分比更低,表明与正常骨髓相比,增殖池更小。A.M.L.患者在第一个疗程治疗后实现完全缓解的可能性与治疗前S期细胞的百分比相关。A.M.L.缓解时,增殖模式恢复正常。